Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323806 (US10189809, Compound I-1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323807 (US10189809, Compound I-3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323808 (US10189809, Compound I-26) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323809 (US10189809, Compound I-27) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323810 (US10189809, Compound I-33) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323811 (US10189809, Compound I-42) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323812 (US10189809, Compound I-45) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323813 (US10189809, Compound I-4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323814 (US10189809, Compound I-49) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323815 (US10189809, Compound I-55) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323816 (US10189809, Compound I-6) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323817 (US10189809, Compound I-61) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323818 (US10189809, Compound I-66) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323819 (US10189809, Compound I-71) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323820 (US10189809, Compound I-72) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323821 (US10189809, Compound I-75) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323822 (US10189809, Compound I-83) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323823 (US10189809, Compound I-84) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323824 (US10189809, Compound I-85) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323825 (US10189809, Compound I-86) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323826 (US10189809, Compound I-87) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323827 (US10189809, Compound I-92) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323828 (US10189809, Compound I-93) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323829 (US10189809, Compound I-96) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM50175274 (CHEMBL3809864 | US10189809, Compound I-97) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323831 (US10189809, Compound I-98) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323832 (US10189809, Compound I-99) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323833 (US10189809, Compound I-100) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323834 (US10189809, Compound I-101) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323835 (US10189809, Compound I-102) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323836 (US10189809, Compound I-103) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323837 (US10189809, Compound I-104) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323838 (US10189809, Compound I-105) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323839 (US10189809, Compound I-106) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323840 (US10189809, Compound I-107) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323841 (US10189809, Compound I-108) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323842 (US10189809, Compound I-109) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323843 (US10189809, Compound I-110) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323844 (US10189809, Compound I-111) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323845 (US10189809, Compound I-112 | US10189809, Compound ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323846 (US10189809, Compound I-113) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323847 (US10189809, Compound I-114) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323848 (US10189809, Compound I-115) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323849 (US10189809, Compound I-116) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323850 (US10189809, Compound I-118) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323851 (US10189809, Compound I-119) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323852 (US10189809, Compound I-121) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323853 (US10189809, Compound I-122) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323854 (US10189809, Compound I-125) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323855 (US10189809, Compound I-126) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 198 total ) | Next | Last >> |